P6215Prognostic value of advanced lung cancer inflammation index in patients with chronic heart failure: a prospective comparative study with cardiac I-123 metaiodobenzylguanidine imaging

MLA

Shunsuke Tamaki, et al. “P6215Prognostic Value of Advanced Lung Cancer Inflammation Index in Patients with Chronic Heart Failure: A Prospective Comparative Study with Cardiac I-123 Metaiodobenzylguanidine Imaging.” European Heart Journal, vol. 39, Aug. 2018. EBSCOhost, https://doi.org/10.1093/eurheartj/ehy566.p6215.

APA

Shunsuke Tamaki, T Yamada, T Morita, Eiji Fukuhara, Yoshio Furukawa, Y Iwasaki, I Ikeda, T Kawai, M Seo, A Kikuchi, Mitsuru Abe, J Nakamura, Masatake Fukunami, & M Kawasaki. (2018). P6215Prognostic value of advanced lung cancer inflammation index in patients with chronic heart failure: a prospective comparative study with cardiac I-123 metaiodobenzylguanidine imaging. European Heart Journal, 39. https://doi.org/10.1093/eurheartj/ehy566.p6215

Chicago

Shunsuke Tamaki, T Yamada, T Morita, Eiji Fukuhara, Yoshio Furukawa, Y Iwasaki, I Ikeda, et al. 2018. “P6215Prognostic Value of Advanced Lung Cancer Inflammation Index in Patients with Chronic Heart Failure: A Prospective Comparative Study with Cardiac I-123 Metaiodobenzylguanidine Imaging.” European Heart Journal 39 (August). doi:10.1093/eurheartj/ehy566.p6215.